[Influencing of Parkinson's syndrome via intervention in the dopamine metabolism].
D000109:Acetylcholine / Q000378:metabolism; D000200:Action Potentials; D001545:Benserazide / Q000627:therapeutic use; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D004298:Dopamine / Q000096:biosynthesis / Q000378:metabolism* / Q000494:pharmacology; D004338:Drug Combinations; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy / Q000378:metabolism*; D011984:Sensory Receptor Cells / Q000187:drug effects; D013569:Synapses / Q000503:physiopathology; D009435:Synaptic Transmission
D004338:Drug Combinations; D004295:Dihydroxyphenylalanine; D001545:Benserazide; D000109:Acetylcholine; D004298:Dopamine
De beïnvloeding van het Parkinsonsyndroom via ingrepen in de dopaminehuishouding.